
Secuencia (N → C)MRWQEMGYIFYPRKLR
MOTS-c es un péptido de 16 aminoácidos descrito por primera vez en 2015. Es uno de los pocos péptidos codificados en el genoma de la mitocondria y no en el del núcleo. En modelos celulares y animales participa en la regulación del metabolismo de la glucosa y en la respuesta celular al estrés metabólico.


Videos de creadores independientes en YouTube. BioVantix no los produce ni los respalda, y no son instrucciones de uso. Se cargan desde YouTube solo al reproducirlos.
Para quien quiera profundizar: cómo actúa, qué encontraron los estudios y las fuentes.
Lo que se ha observado en células y ratones.
Lo que aún no sabemos. No hay ensayos clínicos publicados que hayan administrado MOTS-c a personas. Un análogo relacionado (CB4211) llegó a fase 1b. Los resultados en ratones no se trasladan necesariamente a humanos.
| Longitud | 16 aminoácidos |
|---|---|
| Fórmula molecular | C101H152N28O22S2 |
| Masa molecular | ≈ 2174,6 g/mol |
| Número CAS | 1627580-64-6 |
| Forma | Polvo liofilizado |
| Almacenamiento | −20 °C, protegido de la luz |
| Contenido | 40 mg por vial |
Ficha actualizada el 16 de noviembre de 2026
MOTS-c is a short peptide encoded by the mitochondrial genome and described in the scientific literature as a member of the mitochondrial-derived peptide (MDP) family. Publications on MDPs describe these peptides in the context of mitochondrial signaling and inter-organelle communication in experimental systems.
Reports on MOTS-c describe its identification in cellular compartments, including the mitochondria and the nucleus, under defined experimental conditions. Observations regarding the peptide's localization and molecular interactions are limited to non-clinical research settings and are presented as descriptive findings in cell- and animal-based studies.
All references to MOTS-c are confined to mechanistic and observational research contexts and do not extend beyond laboratory research.
Sequence: Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg Molecular Formula: C101H152N28O22S2 Molecular Weight: 2174.64 g/mol PubChem SID: 255386757 CAS Number: 1627580-64-6 Reported Synonyms: Mitochondrial 12S rRNA-c Open Reading Frame, MT-RNR1
MOTS-c is a 16-amino acid peptide whose primary structure and molecular composition have been characterized in biochemical research sources. Structural descriptions are limited to physicochemical properties and reported sequence information derived from non-clinical research references.
In the scientific literature, MOTS-c has been referenced in non-clinical research involving cellular assays and animal studies. These publications describe experimental contexts in which molecular interactions, signaling components, and markers associated with metabolic pathways were observed and documented.
Reported research applications include the investigation of:
All reported applications are limited to descriptive research conducted in controlled laboratory environments.
In preclinical publications, the mechanisms associated with MOTS-c are described in relation to intracellular signaling pathways involved in molecular energy-sensing and stress-response networks, including components of the AMPK signaling pathway.
Additional references describe experimental observations of MOTS-c localization within the nucleus under defined laboratory conditions, together with reported associations involving the transcriptional regulation of nuclear-encoded genes. These descriptions are limited to molecular and biochemical observations within experimental systems.
All pathway-related descriptions are restricted to non-clinical research contexts and do not imply functional outcomes.
Preclinical studies cited in the scientific literature describe observations involving MOTS-c in cellular and animal model systems. Reported findings include measurements of signaling-associated proteins, metabolite profiles, and gene expression markers recorded under defined experimental conditions.
Additional publications describe associations between MOTS-c and molecular characteristics observed in experimental models of metabolic stress and mitochondrial dysfunction. All reported findings are limited to the experimental systems employed.
MOTS-c is supplied as research-grade peptide material. Its identity and composition have been characterized using analytical techniques commonly applied to research peptides, including chromatographic methods and mass spectrometry.
The above literature was researched, edited, and organized by Dr. Logan, M.D. Dr. Logan holds an M.D. from Case Western Reserve University School of Medicine and a bachelor's degree in Molecular Biology.
Dr. Changhan David Lee, co-author of "MOTS-c: A Novel Mitochondrial-Derived Peptide Regulating Muscle and Fat Metabolism" and "The Mitochondrial-Encoded Peptide MOTS-c Translocates to the Nucleus to Regulate Nuclear Gene Expression in Response to Metabolic Stress", is a researcher at the USC Leonard Davis School of Gerontology.
Pinchas Cohen, M.D., is Dean of the USC Leonard Davis School of Gerontology, Executive Director of the Ethel Percy Andrus Gerontology Center, and holder of the William and Sylvia Kugel Dean's Chair in Gerontology. He is recognized for his research on mitochondrial peptides and their potential therapeutic relevance to diabetes, Alzheimer's disease, and other age-related conditions. Dr. Cohen's current research focuses on the emerging field of mitochondrial-derived peptides, which he discovered. These peptides include Humanin, a 24-amino acid peptide encoded within the mitochondrial 16S rRNA, described as a novel metaboloprotective and centrally acting insulin-sensitizing factor representing a potential therapeutic and diagnostic target for diabetes and related diseases. Other mitochondrial peptides of interest include MOTS-c, a second peptide encoded by a small open reading frame within the mitochondrial 12S region, and SHLP2, a peptide encoded by the light strand of the mitochondrial 16S rRNA region.
Dr. Changhan David Lee and Dr. Pinchas Cohen are referenced as leading scientists involved in the research and development of MOTS-c. These physicians/scientists do not endorse or recommend the purchase, sale, or use of this product for any purpose. There is no affiliation or relationship, express or implied, between Peptide Sciences and these physicians. The purpose of referencing these scientists is solely to acknowledge and credit their extensive research and development efforts related to this peptide. Dr. Changhan David Lee is cited in references [1] and [3]. Dr. Pinchas Cohen is cited in reference [9].
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.
The products offered on this website are supplied exclusively for in vitro studies. In vitro studies (Latin for "in glass") are conducted outside the body. These products are not drugs or pharmaceuticals and have not been approved by the FDA to prevent, treat, or cure any disease or medical condition. Introduction of these products into the body, whether in humans or animals, is strictly prohibited by law.
For laboratory research use only. Not for human, medical, diagnostic, or veterinary use.